Keyphrases
Atrophy
100%
Clinical Correlation
100%
Brain Atrophy
100%
Multiple Sclerosis Treatment
100%
Natalizumab
100%
Atrophy Patterns
100%
Gray Matter
60%
Cerebellum
60%
Physical Disability
60%
Multiple Sclerosis
40%
Gray Matter Volume
40%
Thalamic Volume
40%
Memory Impairment
20%
Anatomical Structure
20%
Cognitive Function
20%
Hippocampus
20%
Inflammatory Process
20%
Anatomical Location
20%
Volume Loss
20%
Cognitive Dysfunction
20%
Central Nervous System
20%
Neurodegenerative Processes
20%
MRI Scan
20%
Therapeutic Approaches
20%
Amygdala
20%
Neuroprotective Role
20%
Globus Pallidus
20%
Corpus Callosum
20%
Cognitive Profile
20%
Relapsing-remitting multiple Sclerosis
20%
Demyelinating Diseases
20%
MS Patients
20%
Image Segmentation Techniques
20%
Atrophy Rate
20%
Cerebellar Atrophy
20%
Disability Progression
20%
Automatic Image Segmentation
20%
Cognitive Regions
20%
Relapsing-remitting MS
20%
Neuroscience
Multiple Sclerosis
100%
Gray Matter
100%
Natalizumab
100%
Cerebellum
80%
Thalamus
60%
Cognitive Disorders
20%
Cognitive Function
20%
Neuroprotective Agent
20%
Hippocampus
20%
Central Nervous System
20%
Neurodegenerative Process
20%
Magnetic Resonance Imaging
20%
Amygdala
20%
Memory Disorder
20%
Globus pallidus
20%
Corpus Callosum
20%
Relapsing Remitting Multiple Sclerosis
20%
Demyelinating Disorder
20%